Here are five insights:
1. All of EIT’s interbody products are available to HCA’s 177 hospitals and 119 surgery centers.
2. EIT offers products for cervical procedures, anterior lumbar interbody fusions, transforaminal lumbar interbody fusions and posterior lumbar interbody fusions.
3. The company’s offerings feature EIT Cellular Titanium, 3-D-printed porous titanium. The material is intended to optimize cell proliferation and bone ingrowth.
4. Ortho Sales Partners handled the contract process for EIT.
5. EIT is also working on an action plan with HCA to determine the economic impact of its technology on fusion rates, implant costs and osteobiologic costs.
More articles on devices:
Medtronic purchases minimally invasive device company in estimated $44.8M deal: 3 insights
Most orthopedic device educational material overly complex for patients — 4 insights
Smith & Nephew, Stryker & more: 7 device company mergers, acquisitions & agreements
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.